pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Emory University

updated 6mo ago

Emory University is a private research university in Atlanta, Georgia, United States. It was founded in 1836 as Emory College by the Methodist Episcopal Church and named in honor of Methodist bishop John Emory. Its main campus is in Druid Hills, four miles from downtown Atlanta.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagType 2 Diabetes2 co-mentions · 2 sources
  • tagImmunology2 co-mentions · 2 sources
  • tagHepatology2 co-mentions · 2 sources
  • tagSickle Cell Disease2 co-mentions · 2 sources
  • drugAlzheimer's Disease2 co-mentions · 2 sources
  • tagAlzheimer's Disease2 co-mentions · 2 sources
  • tagCardiology1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
34
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase4Weight Loss Aid in an Exposed Populationcompletedn=100
  • phase2Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancernot yet recruitingn=88
  • phase2Phase 2 DoceRamPem for Patients With Metastatic or Recurrent NSCLC Who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockadeactive not recruitingn=30
  • phase2Baricitinib Curative Repression of HIV-1not yet recruitingn=35
  • phase1VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Canceractive not recruitingn=35
  • phase1VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanomaactive not recruitingn=41
  • phase2Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantterminatedn=3
  • phase1Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastasesterminatedn=1
🐶 Hiring Signal
No open roles indexed yet — view Emory University jobs →

News

  • ‘They’ve been misdiagnosed for too long’: Researchers use 10-protein panel to improve ALS detection
    By the time a neurodegenerative condition has been diagnosed, it's often too late. At the point of detection, the disease may already be causing irreversible damage, fueling an urgent search for wa…
    fiercebiotech · 9d ago
  • SimBioSys nabs FDA clearance for Nvidia-powered, MRI-derived breast cancer recurrence tool
    SimBioSys has been given FDA clearance of the Nvidia-powered TumorSight Risk, an AI and MRI-derived prognostic tool for assessing the risk of a breast cancer coming back.
    fiercebiotech · 1mo ago
  • Breast cancer can behave differently in older women. This physician is making more tailored treatments a reality
    There’s increasing evidence that older women with breast cancer could benefit from more tailored treatments. STAT Wunderkind Neil Carleton is working to make that a reality.
    stat · 1mo ago
  • In this hospital, pulse oximeters went from overestimating to underestimating blood oxygen. Why?
    Researchers found pulse oximeters went from overestimating blood oxygen levels to underestimating them; inaccuracies were worse in patients of color.
    stat · 1mo ago
  • FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
    In a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, turning a contentious regulatory review into a landmark win that opens a new…
    fiercebiotech · 2mo ago
  • Opinion: It’s time to take the gloves off during vaccination
    Most of the time, it’s unnecessary to use gloves to administer a flu shot, write Cassandra Thiel and Preeti Jaggi.
    stat · 2mo ago
  • A winner, a loser, and a mid-stage signal from a major cardiology research conference
    The mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news from Morning Rounds
    stat · 2mo ago
  • Nurse practitioner trainees find themselves stymied by shortage of clinical mentors
    Nurse practitioner students face a preceptor shortage, often paying thousands to secure clinical supervision.
    stat · 2mo ago
  • Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hint
    Experts ask: How can we better reach out to people facing Medicaid renewal deadlines and support them through the paperwork requirements?
    stat · 3mo ago
  • Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
    CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.
    stat · 4mo ago
view all news mentions →
identifiers
source
globaldata
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?